Search results
Results from the WOW.Com Content Network
Psychologists have developed different treatments to assist children and adolescents suffering from depression, though the legitimacy of the diagnosis of childhood depression as a psychiatric disorder, as well as the efficacy of various methods of assessment and treatment, remains controversial.
In medicine, a contraindication is a condition (a situation or factor) that serves as a reason not to take a certain medical treatment due to the harm that it would cause the patient. [ 1 ] [ 2 ] Contraindication is the opposite of indication , which is a reason to use a certain treatment.
Research shows asthma and depression are untreated or under-treated in children. Experts share signs of both in kids and share treatment options. Research shows asthma and depression are untreated ...
Treatment guidelines from the National Institute of Health and Clinical Excellence [37] recommend against the use of SSRIs in this disorder. Those from the American Psychiatric Association note that SSRIs confer no advantage regarding weight gain, but that they may be used for the treatment of co-existing depression, anxiety, or OCD. [38]
ECT can be used in the treatment for those with major depressive disorder, depressed bipolar disorder, manic bipolar disorder, schizophrenia, manic excitement and catatonia. [7] "Decision to conduct ECT therapy usually comes after there has been failure in other forms of treatment, including medication and psychotherapy". [7]
Imipramine is primarily used for the treatment of depression and certain anxiety disorders, including acute post-traumatic stress reactions. A significant amount of research regarding its efficacy on acute post-traumatic stress in children and adolescents has focused on trauma resulting from burn-injuries.
Tranylcypromine is used to treat major depressive disorder, including atypical depression, especially when there is an anxiety component, typically as a second-line treatment. [10] It is also used in depression that is not responsive to reuptake inhibitor antidepressants, such as the SSRIs , TCAs , or bupropion . [ 11 ]
There has been much debate as to whether reboxetine is more efficacious than placebo in the treatment of depression. According to a 2009 meta-analysis of 12 second-generation antidepressants, reboxetine was no more effective than placebo, and was "significantly less" effective and less acceptable than the other drugs in treating the acute-phase of adults with unipolar major depression.